EMP3 and hepatocellular carcinoma: These aforementioned studies indicate the potential tumor promoting functions of EMP3 in other cancer types including oligodendroglioma, breast carcinoma, urothelial carcinoma, and hepatoma, suggesting that the roles of EMP3 in cancer progression might depend on cancer types.